Saad Mark E

CIK 00012959133 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001295913

Recent Transactions

50 trades

Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-06-08+1,429→ 11,431 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2026-06-08−1,429→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2026-06-05+1,721→ 1,721 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-12-31−6,231→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-12-31$4.95/sh+31,346→ 41,348 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-12-31$165.18/sh−31,346→ 10,002 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-12-31−31,346→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-12-31$8.02/sh+6,231→ 16,233 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-12-31$165.18/sh−6,231→ 10,002 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-05$9.00/sh+9,127→ 19,129 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-09-05−9,127→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-05$125.07/sh−9,127→ 10,002 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-06-06+3,166→ 3,166 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2025-06-06+1,429→ 1,429 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-02-21+1,494→ 1,494 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-09-11−11,016→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-09-11$91.31/sh−11,016→ 10,002 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-09-11$3.67/sh+11,016→ 21,018 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-06-07+5,799→ 5,799 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-02-27+1,519→ 1,519 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2023-06-02+5,681→ 5,681 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2023-03-02+2,224→ 2,224 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2022-06-03+16,976→ 16,976 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2022-03-04+2,337→ 2,337 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-17$34.40/sh+100→ 100 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-17$34.45/sh+100→ 100 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-17$34.40/sh+100→ 100 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-17$34.53/sh+3,000→ 10,002 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2021-06-04+7,325→ 7,325 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2021-03-05+1,241→ 1,241 total
Award
Catheter Precision, Inc.$VTAK
Common Stock
2021-01-05+8,227→ 13,750 total
Award
Catheter Precision, Inc.$VTAK
Common Stock
2020-10-12+100,000→ 138,085 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2020-06-05+13,000→ 13,000 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2020-03-17+3,789→ 3,789 total
Award
Catheter Precision, Inc.$VTAK
Stock Option (Right to Buy)
2020-01-06+49,576→ 49,576 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2019-06-07+13,000→ 13,000 total
Award
Catheter Precision, Inc.$VTAK
Common Stock
2019-06-06+29,850→ 38,085 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-05-23$22.33/sh+3,500→ 7,002 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2019-03-19+29,387→ 29,387 total
Award
Catheter Precision, Inc.$VTAK
Common Stock
2018-10-04+8,235→ 8,235 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Options (right to buy)
2018-06-01+13,000→ 13,000 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2018-03-12+32,602→ 32,602 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2017-03-15+31,346→ 31,346 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2017-03-15+11,000→ 11,000 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2016-05-27+6,231→ 6,231 total
Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2015-11-24$5.94/sh+3,502→ 3,502 total
Award
Axsome Therapeutics, Inc.$AXSM
8% Convertible Note
2015-11-24+3,502→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2015-11-19+9,127→ 9,127 total
Disposition to Issuer
PLUS THERAPEUTICS, INC.$PSTV
Restricted Stock (Common Stock)
2013-01-31−14,070→ 138,430 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Employee Stock Option
2013-01-31+150,000→ 845,000 total

Companies

Recent Filings

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007

View on SEC.gov